Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853229 · ClinicalTrials.gov registry record · Phase 2
Pregabalin for the Treatment of Vulvodynia
A Phase 2 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00853229 is a Phase 2 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 16 participants.
The verdict
NCT00853229, a Phase 2 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pregabalin is effective in the treatment of vulvodynia.
Interventions
- DRUG pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853229
The ClinicalTrials.gov registry entry for NCT00853229 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pregabalin is the first listed.
NCT00853229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853229 about?
NCT00853229 is a clinical study titled "Pregabalin for the Treatment of Vulvodynia". The purpose of this study is to determine whether pregabalin is effective in the treatment of vulvodynia.
What is the current status of trial NCT00853229?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2009-02. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00853229?
The interventions under investigation include: pregabalin (DRUG).
Who is sponsoring clinical trial NCT00853229?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.